APOE and Alzheimer disease: The group-specific associations indicate genetic heterogeneity of plasma metabolites in the APOE 19q13.3 locus, which is in line with our previous studies that demonstrated complex LD structure differentially affects AD risk in this locus (Kulminski et al., 2018, 2020a,b; Nazarian et al., 2022a,b).